Crossmark

Signalling mechanisms and cellular functions of SUMO

Crossref DOI link: https://doi.org/10.1038/s41580-022-00500-y

Published Online: 2022-06-24

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vertegaal, Alfred C. O. http://orcid.org/0000-0002-7989-0493
License Information

Text and Data Mining valid from 2022-06-24

Version of Record valid from 2022-06-24
More Information

Article History

Accepted: 23 May 2022

First Online: 24 June 2022

Competing interests

: The author receives funding from Millennium-Takeda for research on the SUMO E1 inhibitor TAK981.